Yalan Wang
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Oncology top 10%
- PARP inhibition in cancer therapy
Papers in
-
- RNA modifications and cancer 8
- Epigenetics and DNA Methylation 7
- Biochemical and Molecular Research 6
- Cell death mechanisms and regulation 5
- Oncology 37
- PARP inhibition in cancer therapy 27
- Co-authors
- Yi Tang (20 shared papers)Ming Xiao (19 shared papers)Zhong‐Jian Yang (1 shared paper)Xiao‐Niu Peng (1 shared paper)Qu‐Quan Wang (1 shared paper)Shan Liang (1 shared paper)Xue‐Feng Yu (1 shared paper)Min Li (1 shared paper)
- Journals
- International Journal of Molecular Medicine (4 papers)Scientific Reports (3 papers)Oncology Reports (3 papers)Pathology & Oncology Research (3 papers)Molecules (2 papers)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Yalan Wang
94 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 137
- Hepatology 247
- Oncology 263
- Physiology 41
- Renewable Energy, Sustainability and the Environment 132
- Epidemiology 254
Countries citing papers authored by Yalan Wang
This map shows the geographic impact of Yalan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yalan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yalan Wang more than expected).
Fields of papers citing papers by Yalan Wang
This network shows the impact of papers produced by Yalan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yalan Wang. The network helps show where Yalan Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yalan Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 106 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 252 | |
| 2 | 2011 | 169 | |
| 3 | 2015 | 115 | |
| 4 | 2019 | 93 | |
| 5 | 2019 | 57 | |
| 6 | 2010 | 38 | |
| 7 | 2023 | 29 | |
| 8 | 2020 | 27 | |
| 9 | 2013 | 26 | |
| 10 | 2019 | 26 | |
| 11 | 2016 | 23 | |
| 12 | 2013 | 23 | |
| 13 | 2019 | 23 | |
| 14 | 2009 | 22 | |
| 15 | 2019 | 22 | |
| 16 | 2016 | 22 | |
| 17 | 2021 | 21 | |
| 18 | 2016 | 20 | |
| 19 | 2022 | 19 | |
| 20 | 2023 | 19 |
About Yalan Wang
Yalan Wang is a scholar working on Molecular Biology, Oncology, Immunology, Epidemiology and Cancer Research, having authored 106 papers that have together received 1.5k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (27 papers), Toxin Mechanisms and Immunotoxins (12 papers), RNA modifications and cancer (8 papers), Epigenetics and DNA Methylation (7 papers), Biochemical and Molecular Research (6 papers), Ferroptosis and cancer prognosis (6 papers), Ophthalmology and Visual Impairment Studies (5 papers) and Cell death mechanisms and regulation (5 papers). The work is most often cited by research in Hepatology (247 citations), Oncology (263 citations), Physiology (41 citations), Renewable Energy, Sustainability and the Environment (132 citations) and Epidemiology (254 citations). Yalan Wang has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Yi Tang, Ming Xiao, Zhong‐Jian Yang, Xiao‐Niu Peng, Qu‐Quan Wang, Shan Liang, Xue‐Feng Yu, Min Li, Fei‐Fei Jin and Malte F. Stuecker. Their work appears in journals such as International Journal of Molecular Medicine, Scientific Reports, Oncology Reports, Pathology & Oncology Research and Molecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.